Long-term outcomes of a prospective randomized trial of <sup>131</sup>Cs/<sup>125</sup>I permanent prostate brachytherapy.

Moran, Brian J; Koroulakis, Antony; Decesaris, Cristina; Braccioforte, Michelle H; Amin, Neha; Agarwal, Manuj

Long-term outcomes of a prospective randomized trial of ¹³¹Cs/¹²⁵I permanent prostate brachytherapy.

Moran, Brian J; Koroulakis, Antony; Decesaris, Cristina; Braccioforte, Michelle H; Amin, Neha; Agarwal, Manuj.

Afiliação

Moran BJ; Prostate Cancer Foundation of Chicago, Westmont, IL.
Koroulakis A; Department of Radiation Oncology, University of Maryland Medical Center, Baltimore, MD.
Decesaris C; Department of Radiation Oncology, University of Maryland Medical Center, Baltimore, MD.
Braccioforte MH; Prostate Cancer Foundation of Chicago, Westmont, IL; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD.
Amin N; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD.
Agarwal M; Department of Radiation Oncology, Perelman Center for Advanced Medicine, University of Pennsylvania Philadelphia, PA. Electronic address: magarwalmd@gmail.com.

Brachytherapy ; 20(1): 38-43, 2021.

Article em En | MEDLINE | ID: mdl-33059997

Assuntos

Braquiterapia; Neoplasias da Próstata; Antagonistas de Androgênios; Braquiterapia/métodos; Radioisótopos de Césio; Seguimentos; Humanos; Radioisótopos do Iodo; Masculino; Estudos Prospectivos; Antígeno Prostático Específico; Neoplasias da Próstata/radioterapia; Qualidade de Vida

Palavras-chave

125I; 131Cs; Cesium; Iodine; LDR; brachytherapy; isotope; low dose rate; prostate

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google